Bruker Corp (BRKR)
56.22
+2.85
(+5.34%)
USD |
NASDAQ |
Nov 21, 16:00
56.24
+0.02
(+0.03%)
After-Hours: 20:00
Bruker Enterprise Value: 10.71B for Nov. 21, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 10.71B |
| November 20, 2024 | 10.28B |
| November 19, 2024 | 9.500B |
| November 18, 2024 | 9.676B |
| November 15, 2024 | 9.962B |
| November 14, 2024 | 10.45B |
| November 13, 2024 | 10.66B |
| November 12, 2024 | 10.68B |
| November 11, 2024 | 10.77B |
| November 08, 2024 | 10.94B |
| November 07, 2024 | 11.36B |
| November 06, 2024 | 11.13B |
| November 05, 2024 | 11.48B |
| November 04, 2024 | 11.18B |
| November 01, 2024 | 11.17B |
| October 31, 2024 | 10.77B |
| October 30, 2024 | 11.06B |
| October 29, 2024 | 10.99B |
| October 28, 2024 | 11.05B |
| October 25, 2024 | 10.96B |
| October 24, 2024 | 11.04B |
| October 23, 2024 | 11.23B |
| October 22, 2024 | 11.36B |
| October 21, 2024 | 11.55B |
| October 18, 2024 | 11.65B |
| Date | Value |
|---|---|
| October 17, 2024 | 11.36B |
| October 16, 2024 | 11.47B |
| October 15, 2024 | 11.75B |
| October 14, 2024 | 11.80B |
| October 11, 2024 | 11.97B |
| October 10, 2024 | 11.85B |
| October 09, 2024 | 11.99B |
| October 08, 2024 | 12.03B |
| October 07, 2024 | 12.18B |
| October 04, 2024 | 12.34B |
| October 03, 2024 | 12.16B |
| October 02, 2024 | 12.41B |
| October 01, 2024 | 12.31B |
| September 30, 2024 | 12.65B |
| September 27, 2024 | 12.72B |
| September 26, 2024 | 12.69B |
| September 25, 2024 | 12.21B |
| September 24, 2024 | 12.37B |
| September 23, 2024 | 12.19B |
| September 20, 2024 | 12.25B |
| September 19, 2024 | 12.36B |
| September 18, 2024 | 12.14B |
| September 17, 2024 | 11.87B |
| September 16, 2024 | 11.91B |
| September 13, 2024 | 11.96B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
5.035B
Minimum
Apr 01 2020
14.73B
Maximum
Mar 31 2024
10.08B
Average
10.37B
Median
Mar 21 2022
Enterprise Value Benchmarks
| Azenta Inc | 1.613B |
| Harvard Bioscience Inc | 127.50M |
| Bionano Genomics Inc | 14.35M |
| Akoya Biosciences Inc | 145.08M |
| Singular Genomics Systems Inc | -53.66M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 40.90M |
| Revenue (Quarterly) | 864.40M |
| Total Expenses (Quarterly) | 782.20M |
| EPS Diluted (Quarterly) | 0.27 |
| Gross Profit Margin (Quarterly) | 48.45% |
| Profit Margin (Quarterly) | 4.73% |
| Earnings Yield | 3.70% |
| Operating Earnings Yield | 4.39% |
| Normalized Earnings Yield | 2.958 |